Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
On this page, we will discuss an overview of what women should know about transvaginal mesh, transvaginal mesh in female pelvic reconstructive surgery, reoperation for SUI surgery using transvaginal mesh, and much more.
Important considerations regarding transvaginal mesh implants include, but are not limited to:
If you or a loved one have experienced complications from a transvaginal mesh implant, legal recourse may be available.
Contact TruLaw using the chat on this page for a prompt case evaluation to determine eligibility for a transvaginal mesh lawsuit.
Our experienced legal team offers insights into potential compensation, with settlement estimates ranging between $150,000 and $400,000 based on your injuries.
Transvaginal mesh is utilized in female pelvic reconstructive surgery to provide support to weakened pelvic structures.
This medical intervention addresses a range of pelvic floor disorders.
The pelvic region consists of a complex network of muscles, bones, and organs.
Pelvic muscles provide support to the pelvic organs, including the bladder, bowel, and uterus.
The pubic bone at the front and the spine at the back frame the pelvic floor, with the bladder neck positioned at the front of the pelvic region.
A list of key components within the pelvic anatomy includes:
Pelvic floor disorders encompass a variety of conditions that affect the support and function of the pelvic floor.
Stress urinary incontinence and pelvic organ prolapse are two prominent examples.
Stress urinary incontinence is characterized by the unintentional leakage of urine during physical activity, while pelvic organ prolapse occurs when pelvic organs drop from their normal position into or through the vaginal canal due to weakened support structures.
The common pelvic floor disorders include:
Pelvic Organ Prolapse (POP) is a condition affecting many women, characterized by the descent of pelvic organs into the vaginal canal.
Treatment options range from nonsurgical to various surgical methods, including the use of surgical mesh to provide support.
The variety of transvaginal mesh implants used in POP treatment includes synthetic polypropylene meshes, bioresorbable synthetic materials, and animal tissue grafts.
Discover the wide range of mesh implants available include, but not limited to:
Surgical repair for POP can be executed via different approaches, each with its own methodologies.
A brief summary of the main surgical options:
The effectiveness of surgical interventions varies based on methodology and individual patient conditions.
Here’s a comparative overview of the different surgical methods:
After undergoing surgical procedures for POP, several steps are essential for successful post-surgical care.
Key aspects of post-surgical care include, but are not limited to:
Effective management of complications arising from vaginal mesh implants involves a multi-faceted approach, including precise diagnosis, appropriate surgical interventions, and an understanding of the evolving legal and regulatory landscape.
Early recognition of mesh complications is crucial for patient care.
Complications can manifest as groin pain, debilitating pain, or problems with bowel movements.
Here are key symptoms to watch for:
When mesh complications become severe, transvaginal mesh removal may be required.
This surgical procedure is delicate and hinges on a few critical steps:
Legal and regulatory considerations pertaining to transvaginal mesh have evolved significantly.
Highlighted below are important aspects to keep in mind:
Surgical intervention for stress urinary incontinence (SUI) using transvaginal mesh sometimes necessitates reoperation due to complications or recurrent symptoms.
The following discussion outlines the long-term outcomes and the vital support systems available for patients undergoing these procedures.
In assessing the long-term outcomes of SUI surgery with transvaginal mesh, studies indicate a mix of successes and challenges.
Reoperation rates are a critical measure of surgical success and patient well-being over time.
Here are key findings from long-term studies on SUI surgery using transvaginal mesh:
Support and advocacy play pivotal roles in the journey of patients dealing with transvaginal mesh complications.
These resources provide healthcare advice, emotional backing, and practical information:
In response to safety concerns, the FDA has issued a ban on the sale of transvaginal mesh products for pelvic organ prolapse (POP).
Efficacy and safety concerns have led to increased scrutiny and the eventual removal from the market.
For those seeking alternatives to surgical intervention for POP, a number of non-surgical treatment options are available.
Here are some effective methods patients may consider:
Research continues to progress in the development of experimental therapies and future medical advancements.
Below are some areas of exploration:
Transvaginal mesh has played a significant role in pelvic reconstructive surgery, with a specific focus on transvaginal prolapse repair and efforts to treat stress incontinence.
Advancements in this domain aim to address the nuances and complexities involved in treating POP (pelvic organ prolapse).
The future of transvaginal mesh in pelvic reconstructive surgery includes multiple facets.
Researchers and clinicians are focusing on reducing complications while preserving the procedure’s benefits.
Areas of focus and development include, but are not limited to:
These endeavors collectively aim to safeguard patient health while optimizing the role of transvaginal mesh in treating pelvic organ prolapse and associated conditions.
Complications from vaginal mesh surgeries may vary from mild to severe.
Patients often report chronic pain and infection as frequent issues.
Additionally, mesh erosion and urinary problems are notable concerns following the surgery.
Several methods can be considered for treating prolapse without mesh.
These include pelvic floor physical therapy, pessary insertion, native tissue repair, or a combination of lifestyle changes and conservative management strategies.
Mesh is commonly used in surgeries aimed at correcting pelvic organ prolapse and stress urinary incontinence.
These procedures include sacrocolpopexy for prolapse and mid-urethral mesh slings for incontinence.
Mesh provides structural support where tissue is weakened.
Complications from pelvic mesh may manifest through various symptoms.
Individuals might notice persistent pelvic or groin pain, bleeding, painful intercourse, or recurrent urinary tract infections.
These symptoms warrant immediate medical evaluation.
A bladder sling procedure specifically aims to treat pelvic floor disorders and stress urinary incontinence by supporting the urethra.
In contrast, the broader term “transvaginal mesh placement” may refer to treatment for both incontinence and pelvic organ prolapse via mesh insertion through the vagina.
Surgical mesh is utilized to reinforce the pelvic floor and support weakened tissues.
Its application ranges from addressing pelvic organ prolapse to providing support during bladder sling procedures for stress urinary incontinence.
Mesh acts as a scaffold allowing for tissue integration.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Transvaginal Mesh Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?